Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR8 | P51685 | 16/20 | 0.70 |
| ▸ | KCNH2 | Q12809 | 16/20 | 0.70 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4237911 | 0.91 | CCR8 (0.70) | CCR8KCNH2CYP2D6CYP3A4CYP1A2 | |
| SCHEMBL4243566 | 0.90 | CCR8 (0.77) | CCR8KCNH2CYP2D6CYP3A4CYP1A2 | |
| SCHEMBL5033901 | 0.90 | CCR8 (0.69) | CCR8KCNH2CYP2D6CYP3A4CYP1A2 | |
| SCHEMBL4239397 | 0.89 | CCR8 (0.70) | CCR8KCNH2CYP2D6CYP3A4CYP1A2 | |
| SCHEMBL4235221 | 0.87 | CCR8 (0.70) | CCR8KCNH2CYP2D6CYP3A4CHRM2 | |
| Trifluoroacetic Acid SCHEMBL4237131 | 0.86 | CCR8 (0.70) | CCR8KCNH2CYP2D6CYP3A4CYP1A2 | |
| SCHEMBL4237544 | 0.85 | CCR8 (0.77) | CCR8KCNH2CYP2D6CYP3A4 | |
| SCHEMBL4235585 | 0.85 | CCR8 (0.74) | CCR8KCNH2CYP2D6CYP3A4 | |
| Trifluoroacetic Acid SCHEMBL4243056 | 0.85 | CCR8 (0.64) | CCR8KCNH2CYP2D6CYP3A4CYP1A2 | |
| SCHEMBL4237176 | 0.84 | CCR8 (0.69) | CCR8KCNH2CYP2D6CYP3A4CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1926730-A1 | NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES | AstraZeneca AB (SE) | 2008-06-04 | — | — | EP | claimed |
| WO-2007030061-A1 | NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES | ASTRAZENECA AB (SE) | 2007-03-15 | — | — | WO | claimed |